Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Hauser

Showing results (241-250 of 322) with videos related to

Pageof 33
Sort By:
Nature Communications|May 20, 2024
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2025
Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomographyHenriette Km Reinsberg, Frederike C Oertel, Daniel Casillas, et al.
Neurology|December 23, 2024
Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple SclerosisHannah E Silverman, Alan Bostrom, Alyssa N Nylander, et al.
Lancet (London, England)|October 15, 2017
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialAri J Green, Jeffrey M Gelfand, Bruce A Cree, et al.
Brain : a Journal of Neurology|March 7, 2022
Polygenic risk score association with multiple sclerosis susceptibility and phenotype in EuropeansHengameh Shams, Xiaorong Shao, Adam Santaniello, et al.
Neurology|August 29, 2022
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple SclerosisChristian Cordano, Bardia Nourbakhsh, Hao H Yiu, et al.
JCI Insight|December 5, 2017
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patientsErica L Eggers, Brady A Michel, Hao Wu, et al.
Plos Genetics|January 3, 2009
IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor productionLisa M Maier, Christopher E Lowe, Jason Cooper, et al.
American Journal of Epidemiology|June 5, 2010
Variation within DNA repair pathway genes and risk of multiple sclerosisFarren B S Briggs, Benjamin A Goldstein, Jacob L McCauley, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 yearsStephen L Hauser, Anne H Cross, Kevin Winthrop, et al.
Pageof 33

Showing results (241-250 of 322) with videos related to

Sort By:
Pageof 33
Nature Communications|May 20, 2024
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2025
Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomographyHenriette Km Reinsberg, Frederike C Oertel, Daniel Casillas, et al.
Neurology|December 23, 2024
Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple SclerosisHannah E Silverman, Alan Bostrom, Alyssa N Nylander, et al.
Lancet (London, England)|October 15, 2017
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialAri J Green, Jeffrey M Gelfand, Bruce A Cree, et al.
Brain : a Journal of Neurology|March 7, 2022
Polygenic risk score association with multiple sclerosis susceptibility and phenotype in EuropeansHengameh Shams, Xiaorong Shao, Adam Santaniello, et al.
Neurology|August 29, 2022
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple SclerosisChristian Cordano, Bardia Nourbakhsh, Hao H Yiu, et al.
JCI Insight|December 5, 2017
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patientsErica L Eggers, Brady A Michel, Hao Wu, et al.
Plos Genetics|January 3, 2009
IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor productionLisa M Maier, Christopher E Lowe, Jason Cooper, et al.
American Journal of Epidemiology|June 5, 2010
Variation within DNA repair pathway genes and risk of multiple sclerosisFarren B S Briggs, Benjamin A Goldstein, Jacob L McCauley, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 yearsStephen L Hauser, Anne H Cross, Kevin Winthrop, et al.
Pageof 33